The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
A Boston biotech startup announced a major step towards reversing age-related vision loss. Their experimental gene therapy, ...
The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first ...
Landmark review analyzes 41 human studies to identify which interventions have been shown to slow next-generation epigenetic aging clocks, and which widely discussed longevity interventions remain ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
When you transfer old DNA from an animal into a new cloned cell, you don't get an old clone, but a young one. Therefore the DNA itself must contain all the instructions it ever did. That leaves the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Local researchers including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results